Guardian Pharmacy Services, Inc.
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
GRDN$49.85+6.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
COND
EN
SED
CO
NSOLIDATED STATEMENTS OF OPERATIONS
| Three Months Ended March 31, | ||
|---|---|---|
| (In thousands, except per share amounts) | 2025 | 2026 |
| Revenues | $329,308 | $336,595 |
| Cost of goods sold | 264,959 | 260,286 |
| Gross profit | 64,349 | 76,309 |
| Selling, general, and administrative expenses | 51,344 | 58,634 |
| Operating income | 13,005 | 17,675 |
| Other expenses (income): | ||
| Interest expense | 170 | 154 |
| Other expense (income), net | (271) | (772) |
| Total other expenses (income) | (101) | (618) |
| Income before income taxes | 13,106 | 18,293 |
| Provision for income taxes | 3,833 | 4,749 |
| Net income | 9,273 | 13,544 |
| Less net income (loss) attributable to non-controlling interests | (175) | 249 |
| Net income attributable to Guardian Pharmacy Services, Inc. | $9,448 | $13,295 |
| Basic | $0.15 | $0.21 |
| Diluted | $0.15 | $0.21 |
| Weighted-average Class A and Class B common shares outstanding | ||
| Basic | 62,043 | 63,321 |
| Diluted | 62,914 | 63,692 |
| 1 | See Note 6 Basic and Diluted Net Income Per Share for the number of shares used in the computation of net income per share of Class A and Class B common stock and the basis for the computation of net income per share. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.